Definium Therapeutics (DFTX) Amortizatization of Intangibles (2025 - 2026)

Definium Therapeutics' (DFTX) quarterly Amortizatization of Intangibles came in at -$591000.0 in Q1 2026, down 29.04% on a QoQ basis from -$458000.0 in Q4 2025.

Definium Therapeutics (DFTX) Amortizatization of Intangibles (2025 - 2026) Analysis & Trends

Definium Therapeutics (DFTX) has 2 years of Amortizatization of Intangibles data on file, last reported at -$591000.0 in Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles changed N/A year-over-year to -$591000.0 in Q1 2026; TTM through Mar 2026 was $1.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.8 million, changed N/A from the prior year.
  • Amortizatization of Intangibles for Q1 2026 stood at -$591000.0, down from -$458000.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for DFTX reached as high as $2.4 million in Q2 2025 and fell as low as -$591000.0 in Q1 2026.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Definium Therapeutics 4.64 Bn 4.64 Bn - -591,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -591,000.00
Mar 31, 2026 -591,000.00
Dec 31, 2025 -458,000.00
Dec 31, 2025 -458,000.00
Sep 30, 2025 -143,000.00
Sep 30, 2025 -143,000.00
Jun 30, 2025 2.42 Mn
Jun 30, 2025 2.42 Mn